ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Erasca Inc

Erasca Inc (ERAS)

3.28
0.01
(0.31%)
Closed July 27 4:00PM
3.3477
0.0677
(2.06%)
After Hours: 6:12PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
3.3477
Bid
3.20
Ask
3.35
Volume
1,377,770
3.20 Day's Range 3.45
1.51 52 Week Range 3.45
Market Cap
Previous Close
3.27
Open
3.35
Last Trade
2
@
3.3499
Last Trade Time
Financial Volume
$ 4,539,077
VWAP
3.2945
Average Volume (3m)
2,531,255
Shares Outstanding
173,358,966
Dividend Yield
-
PE Ratio
-4.55
Earnings Per Share (EPS)
-0.72
Revenue
-
Net Profit
-125.04M

About Erasca Inc

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage progr... Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's pipeline includes two clinical-stage programs (ERK and SHP2 inhibitors), two preclinical-stage programs (CNS-penetrant KRAS G12C and EGFR inhibitors), and seven discovery-stage programs targeting other key oncogenic drivers. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Erasca Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ERAS. The last closing price for Erasca was $3.27. Over the last year, Erasca shares have traded in a share price range of $ 1.51 to $ 3.45.

Erasca currently has 173,358,966 shares outstanding. The market capitalization of Erasca is $566.88 million. Erasca has a price to earnings ratio (PE ratio) of -4.55.

ERAS Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.327710.85099337753.023.452.9414806133.10149725CS
41.007743.06410256412.343.452.126518502.81647839CS
121.127750.79729729732.223.451.8125312552.47763747CS
261.627794.63372093021.723.451.6415654932.38026179CS
520.827732.84523809522.523.451.5112162232.27871605CS
156-15.8523-82.564062519.224.471.518516755.07799259CS
260-12.5523-78.945283018915.924.471.518551735.23795549CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 8.24
(150.46%)
48.57M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NBSTWNewbury Street Acquisition Corporation
$ 0.1349
(92.71%)
122.1k
YIBOPlanet Image International Ltd
$ 2.915
(53.43%)
260.07k
CREVCarbon Revolution Public Ltd
$ 9.00
(45.87%)
8.06M
NMHINatures Miracle Holding Inc
$ 0.2035
(-48.06%)
7.69M
TANHTantech Holdings Ltd
$ 0.2585
(-47.23%)
6.75M
DXCMDexCom Inc
$ 64.00
(-40.66%)
53.92M
PSIGPS International Group Ltd
$ 1.42
(-31.40%)
716.26k
POAIPredictive Oncology Inc
$ 1.36
(-27.27%)
6.02M
SLNASelina Hospitality PLC
$ 0.0305
(-18.88%)
408.61M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NVDANVIDIA Corporation
$ 113.06
(0.69%)
293.33M
SQQQProShares UltraPro Short QQQ
$ 9.10
(-2.88%)
176.49M
SGMOSangamo Therapeutics Inc
$ 0.8612
(28.15%)
123.71M

Your Recent History

Delayed Upgrade Clock